Author

N. Azzam

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:multiome· 1 Organism:zebrafish· 1

Frequent Co-Authors

A. Camacho-Magallanes· 1 shared A. Pietrobon· 1 shared A. S. Kristof· 1 shared C. Dore· 1 shared C. Xue· 1 shared E. Lian· 1 shared G. Musso· 1 shared J. N. Berman· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Camacho-Magallanes

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Three-dimensional drug screen identifies HDAC inhibitors as therapeutic agents in mTORC1-driven lymphangioleiomyomatosis

A. Pietrobon, J. Yockell-Lelievre, N. Melong, L. J. Smith, S. P. Delaney, N. Azzam, C. Xue, N. Merwin, E. Lian, A. Camacho-Magallanes, C. Dore, G. Musso, L. M. Julian, A. S. Kristof, R. Y. Tam, , W. L. Stanford

A 3D drug screen identified HDAC inhibitors as effective against mTORC1-driven lymphangioleiomyomatosis by reducing invasion and selectively killing TSC2-/- cells.

bioRxiv · Jul 3, 2021Cell Biology